Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID)

Common variable immunodeficiency disorder (CVID) is the commonest cause of primary antibody failure in adults and children, and characterized clinically by recurrent bacterial infections and autoimmune manifestations. Several innate immune defects have been described in CVID, but no study has yet in...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 5; no. 9; p. e12652
Main Authors: Carvalho, Karina I, Melo, Karina M, Bruno, Fernanda R, Snyder-Cappione, Jennifer E, Nixon, Douglas F, Costa-Carvalho, Beatriz T, Kallas, Esper G
Format: Journal Article
Language:English
Published: United States Public Library of Science 09-09-2010
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Common variable immunodeficiency disorder (CVID) is the commonest cause of primary antibody failure in adults and children, and characterized clinically by recurrent bacterial infections and autoimmune manifestations. Several innate immune defects have been described in CVID, but no study has yet investigated the frequency, phenotype or function of the key regulatory cell population, natural killer T (NKT) cells. We measured the frequencies and subsets of NKT cells in patients with CVID and compared these to healthy controls. Our results show a skewing of NKT cell subsets, with CD4+ NKT cells at higher frequencies, and CD8+ NKT cells at lower frequencies. However, these cells were highly activated and expression CD161. The NKT cells had a higher expression of CCR5 and concomitantly expression of CCR5+CD69+CXCR6 suggesting a compensation of the remaining population of NKT cells for rapid effector action.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Conceived and designed the experiments: KIC JESC DFN EGK. Performed the experiments: KIC FRB. Analyzed the data: KIC EGK. Contributed reagents/materials/analysis tools: DFN EGK. Wrote the paper: KIC DFN BTCC EGK. Clinical care and clinical data: KMM BTCC.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0012652